Methods for controlling blood pressure and reducing dyspnea in heart failure
US10881645B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2013 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Oct 26, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for controlling, maintaining, or reducing blood pressure, and/or for treating, preventing, or alleviating symptoms such as dyspnea, in a patient suffering from or susceptible to acute heart failure. The methods involve the administration of an effective amount of a pharmaceutical composition comprising a short acting dihydropyridine compound such as clevidipine. The pharmaceutical composition may be administered at an initial dose, and if blood pressure is not controlled or maintained within a target blood pressure range or reduced to within a target blood pressure range, the initial dose may be titrated to achieve a blood pressure within the target blood pressure range. The patient may have a systolic blood pressure of about 120 mmHg or above.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.